Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ana M. Borras"'
Autor:
Lewis C. Cantley, George N. Naumov, John V. Heymach, Ana M. Borras, Bruce E. Johnson, Christopher Michael Gale, Toru Mukohara, Emily T Jarrell, Beow Y. Yeap, Pasi A. Jänne, Jeffrey A. Engelman, Jason Sun, Kreshnik Zejnullahu, Sean Tracy, Xiaojun Zhao, Eugene Lifshits
Publikováno v:
Journal of Clinical Investigation. 116:2695-2706
EGFR is frequently mutated and amplified in lung adenocarcinomas sensitive to EGFR inhibitors gefitinib and erlotinib. A secondary mutation, T790M, has been associated with acquired resistance but has not been shown to be sufficient to render EGFR mu
Autor:
Elizabeth A. Maher, Balazs Halmos, Matthew Meyerson, Jeffrey C. Lee, Neal I. Lindeman, Victoria A. Joshi, Robert J. Distel, Pasi A. Jänne, Andrew M. Rogers, Ana M. Borras, Bruce E. Johnson, Hema Liyanage, Yanan Kuang
Publikováno v:
Clinical Cancer Research. 12:751-758
Purpose: Mutations in the epidermal growth factor receptor (EGFR) are associated with clinical and radiographic responses to EGFR tyrosine kinase inhibitors gefitinib and erlotinib. Currently available methods of EGFR mutation detection rely on direc
Autor:
Pamela L. Sheridan, Konstantin Khrapko, Maxwell C. Furr, Joel A. Lawitts, Xiaomin Zhang, Ana M. Borras, Jianyuan Chai, Ravi P. Misra, Gohar Azhar, Jeanne Y. Wei
Publikováno v:
Journal of Biological Chemistry. 276:40033-40040
Serum response factor (SRF) is a key regulator of a number of extracellular signal-regulated genes important for cell growth and differentiation. A form of the SRF gene with a double mutation (dmSRF) was generated. This mutation reduced the binding a
Autor:
Stuart A. Aaronson, Corinne L. Reimer, Sam W. Lee, Siavash K. Kurdistani, Ana M. Borras, Jennifer R. Garreau, Mirra Chung
Publikováno v:
Journal of Biological Chemistry. 274:11022-11029
Cyclin G, a recent addition to the cyclin family, was initially identified in screens for new src kinase family members and soon thereafter by differential screening for transcriptional targets of the tumor suppressor gene, p53. We have identified cy
Publikováno v:
Virology. 228(1):11-18
Induction of the Epstein-Barr virus lytic cycle in latently infected B cells requires the expression of the immediate-early lytic gene BZLF1. We have previously identified several cis-elements within the BZLF1 promoter that are required for induction
Publikováno v:
The EMBO Journal. 16:143-153
Induction of the Epstein-Barr virus (EBV) lytic cycle by crosslinking surface immunoglobulin is inhibited by the immunosuppressants cyclosporin A (CsA) and FK506. This correlates with the ability of CsA to inhibit Ca2+-dependent transcription of the
Autor:
Pablo Alvarez, Kinjal Shah, Torstein Tengs, Elizabeth Nickerson, Tzu Hsiu Chen, Yuki Yuza, Ralph M. Debiasi, Pasi A. Jänne, Jonathan M. Rothberg, Ana M. Borras, Levi A. Garraway, Michael Egholm, Roman K. Thomas, Christine Lubeski, Karen A. Glatt, Gregory S. Turenchalk, William Brockman, Heidi Greulich, Matthew Meyerson, Konstantin H. Dragnev, Hidefumi Sasaki, Brian Desany, John H. Leamon, Kwok-Kin Wong, Jan Fredrik Simons, Stephen K. Hutchison, Michael T. Ronan, William R. Sellers, Thomas LaFramboise, Jeffrey C. Lee, Edward J. Gutmann, Neal I. Lindeman, Keith O'Neill
Publikováno v:
Nature medicine. 12(7)
The sensitivity of conventional DNA sequencing in tumor biopsies is limited by stromal contamination and by genetic heterogeneity within the cancer. Here, we show that microreactor-based pyrosequencing can detect rare cancer-associated sequence varia
Publikováno v:
Journal of Clinical Oncology. 26:22010-22010
22010 Background: De novo and acquired resistance of HER2+ breast cancer (HBC) totrastuzumab (T) is an important clinical problem, yet the molecular basis underlying resistance is not well understo...
Autor:
Pablo Alvarez, Kinjal Shah, Michael T. Ronan, Hidefumi Sasaki, Jan Fredrik Simons, Torstein Tengs, Levi A. Garraway, Keith O'Neill, Elizabeth Nickerson, Tzu Hsiu Chen, Edward J. Gutmann, John H. Leamon, Ralph M. Debiasi, Ana M. Borras, Christine Lubeski, Karen A. Glatt, Brian Desany, Pasi A. Jänne, Jeffrey C. Lee, Heidi Greulich, Konstantin H. Dragnev, Neal I. Lindeman, Jonathan M. Rothberg, Yuki Yuza, William Brockman, Matthew Meyerson, William R. Sellers, Kwok K. Wong, Stephen K. Hutchison, Michael Egholm, Roman K. Thomas, Gregory S. Turenchalk, Thomas LaFramboise
Publikováno v:
Nature Medicine. 12:1220-1220
Autor:
Alison J. Holmes, Yanan Kuang, M. Taron, Giuseppe Giaccone, Victoria A. Joshi, Pasi A. Jänne, M. Gallegos Ruiz, Andrew M. Rogers, Ana M. Borras, Robert J. Distel
Publikováno v:
Journal of Clinical Oncology. 24:10054-10054
10054 Background: Mutations in the epidermal growth factor receptor (EGFR) are associated with sensitivity and resistance to EGFR inhibitors gefitinib and erlotinib in patients with non-small cell lung carcinoma (NSCLC). Direct sequencing is currentl